Skip to main content
. 2010 May;12(4):277–284. doi: 10.1111/j.1477-2574.2010.00170.x

Table 2.

Details of neoadjuvant chemotherapy regimen (n= 50)

Group Total Strong Weak P-value
Neoadjuvant regimen
FOLFIRI 30 12 18 0.271
FOLFOX 10 3 7
Other 10 2 8
Mean number of courses, n 8 8 8 0.875
Response rate by RECIST26 0.046
Complete response 1 1 0
Partial response 23 11 12
Stable disease 19 5 14
Progressive disease 7 0 7
Portal vein embolization, n 5 2 3 0.765